Full activation of RNaseL in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzyme

Journal of Interferon and Cytokine Research

Volumn 19, Issue 2, 1999, Pages 113-119

  Díaz Guerra, Margarita ^a,b   Rivas, Carmen ^a   Esteban, Mariano ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ENDORIBONUCLEASE L; POLYADENYLIC ACID; PROTEIN KINASE; RIBONUCLEASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INDUCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA ANALYSIS; STRUCTURE ACTIVITY RELATION; VACCINIA VIRUS;

ADENINE NUCLEOTIDES; ANIMALS; ANKYRINS; APOPTOSIS; CELL LINE; ENDORIBONUCLEASES; ENZYME ACTIVATION; ENZYME INDUCTION; OLIGORIBONUCLEOTIDES; PEPTIDE MAPPING; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID;

ANIMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0032979274     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314252     Document Type: Article

References (34)

1. SAMUEL, C.E. (1991). Antiviral actions of interferon. Interferonregulated cellular proteins and their surprisingly selective antiviral activities. Virology 183, 1-11.
2. SEN, G.C., and LENGYEL, P. (1992). The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020.
3. STAEHELI, P. (1990). Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38, 147-200.
4. KERR, I.M., and BROWN, R.E. (1978). pppA2′ p5′ A2′ p5′ A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75, 256-260.
5. JOKLIK, W.K. (1990). In: Virology, B.N. Fields, D.M. Knipe, et al. (eds.) New York: Raven Press, pp. 383-410.
6. CHEBATH, P.J., WHITE, R.F., ANTONIW, J.F., WALESBY, N.J., and KERR, I.M. (1987). Constitutive expression of (2′ -5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330, 587-588.
7. COCCIA, E.M., ROMEO, G., NISSIN, A., MARZIALLI, G., ALBERTINI, R., AFFABRIS, A., BATTISTINI, A., FIORUCCI, G., ORSSATI, R., ROSSI, G.B., and CHEBATH, J. (1990). A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179, 228-233.
8. LI, X.-L., BLACKFORD, J.A., and HAPPEL, B. (1998). RNaseL mediates the antiviral effect of interferon through a selective reduction of viral RNA during encephalomyocarditis virus infection. J. Virol. 72, 2752-2759.
9. DÍAZ-GUERRA, M., RIVAS, C., and ESTEBAN, M. (1997). Inducible expression of the 2-5A-synthetase/RNaseL system results in inhibition of vaccinia virus replication. Virology 227, 220-228.
10. MATRA, R.K., and SIRVERMAN, R.H. (1998). Regulation of human immunodeficiency virus replication by 2′ ,5′-oligoadenylate dependent RNaseL. J. Virol. 72, 1146-1152.
11. LENGYEL, P. (1993). Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. USA 90, 5893-5895.
12. CASTELLI, J.A.C., HASSEL, B.A., WOOD, K.A., LI, X.-L., AMEMIYA, K., DALAKAS, M.C., TORRENCE, P., and YOULE, R.J. (1997). A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186, 967-972.
13. DIAZ-GUERRA, M., RIVAS, C., and ESTEBAN, M. (1997). Activation of the IFN-inducible enzyme RNaseL causes apoptosis of animal cells. Virology 236, 354-363.
14. ZHOU, A., PARANJAPE, J., BROWN, T.L., NIE, H., NAIK, S., DONC, B., CHANG, A., TRAPP, B., FAIRCHILD, R., COLMENARES, C., and SILVERMAN, R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′ ,5′-oligoadenylate-dependent RNaseL. EMBO J 16, 6355-6363.
15. ZHOU, A., HASSEL, B.A., and SILVERMAN, R.H. (1993). Expression cloning of 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell 72, 753-765.
16. BORK, P., and SANDER, C. (1993). A hybrid protein kinase-RNase in an interferon-induced pathway? FEBS Lett. 334, 149-152.
17. HASSEL, B.A., ZHOU, A., SOTOMAYOR, C., MARAN, A., and SILVERMAN, R.H. (1993). A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12, 3297-3304.
18. BENNETT, V. (1992). Ankyrins. J. Biol. Chem. 267, 8703-8706.
19. BORK, P. (1993). Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally. Proteins 17, 363-374.
20. DONG, B., and SILVERMAN, R.H. (1995). 2-5A-Dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270, 4133-4137.
21. TIRASOPHON, W., WELIHINDA, A.A., and KAUFMAN, R.J. (1998). A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Irelp) in mammalian cells. Genes Dev. 12, 1812-1824.
22. SIDRAUSKI, C., and WALTER, P. (1997). The transmembrane kinase Irelp is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell 90, 1031-1039.
23. SUAREZ. P., DÍAZ-GUERRA, M., PRIETO, C., ESTEBAN, M., CASTRO, J.M., NIETO, A., and ORTIN, J. (1996). Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. J. Virol. 70, 2876-2882.
24. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (Eds.) (1987) Current Protocols in Molecular Biology. New York: John Wiley & Sons.
25. FUHRST, T.R., NILES, E.G., STUDIER, F.W., and MOSS, B. (1986). Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122-8126.
26. MOSS, B., ELROY-STEIN, O., MIZUKAMI, T., ALEXANDER, W.A., and FUERST, T.R. (1990). New mammalian expression vectors. Nature 348, 91-92.
27. RODRIGUEZ, J.F., RODRIGUEZ, D., RODRIGUEZ, J.-R., McGOWAN, E.B., and ESTEBAN, M. (1988). Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc. Natl. Acad. Sci. USA 85, 1667-1671.
28. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 27, 365-369.
29. ESTEBAN, M., and PAEZ, E. (1985). The 2-5A system and vaccinia virus. In: The 2-5A System: Molecular and Clinical Aspects of the Interferon Regulated 2-5A Pathway. B.R.G. Williams and R.H. Silverman (eds.) New York: Alan R. Liss, 202, 25-34.
30. RICE, A.P., ROBERTS, W.K., and KERR, I.M. (1984). 2-5A accumulates to high levels in interferon-treated vaccinia virus infected cells in the absence of any inhibition of virus replication. J. Virol. 50, 220-228.
31. LEE, S.B., and ESTEBAN, M. (1993). The interferon-induced double stranded RNA-activated protein kinase inhibits the replication of vaccinia virus. Virology 193, 1037-1041.
32. DONG, B., and SILVERMAN, R.H. (1997). A bipartite model of 2-5A-dependent RNaseL. J. Biol. Chem. 272, 22236-22242.
33. 1/S-specific transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 1069-1077.
34. THOMPSON, C.C., BROWN, T.A., and McKNIGHT, S.L. (1991). Convergence of Etsand Notch-related structural motifs in a heteromeric DNA binding complex. Science 253, 762-768.